ASH 2024: MPN Research Highlights with Dr. Angela Fleischman Discover the latest breakthroughs in Myeloproliferative Neoplasm (MPN) research from ASH 2024 with insights from MPN expert Dr. Angela Fleischman. This year’s conference unveiled progress in understanding and treating MPNs, including Polycythemia Vera (PV), Myelofibrosis (MF), and Essential Thrombocythemia (ET). In this interview, Dr. Fleischman discusses […]
by David Wallace 2024 Patients Are Asking, Episode 2 In this MPN expert interview, Dr. Gaby Hobbs shares her expertise on the various treatment options for Polycythemia Vera (PV). She explains first-line therapies, including phlebotomy, hydroxyurea, interferon (Besremi), Jakafi and highlights the importance of individualized treatment based on patient-specific factors. Watch the full interview to […]
by David Wallace 2024 Patients Are Asking, Episode 1 In our ongoing effort to provide the latest insights and resources for the MPN community, we’re excited to share an informative video on tailoring JAK inhibitor treatment strategies for myelofibrosis. Our interview with MPN expert, Dr. Lucia Masarova covers important aspects of JAK inhibitors, their role […]
by David Wallace ASH 2023 Highlights: Patients Are Asking, Episode 3 Discover the latest MPN research from the ASH 2023 conference with MPN expert, Dr. Lucia Masarova. We cover the latest clinical trials, breakthrough treatments, and innovative approaches to MPN blood cancers. Learn about combination treatments for myelofibrosis and updates on clinical trials for polycythemia […]
Site by: Kaleidoscopic
